Sodium caseinate and alpha-casein inhibit proliferation of the mouse myeloid cell line 32D cl3 via TNF-alpha


Por: Weiss-Steider, Benny, Cordova, Yolanda, Aguiniga-Sanchez, Itzen, Ledesma-Martinez, Edgar, Dominguez-Melendez, Vanihamin, Santiago-Osorio, Edelmiro

Publicada: 1 jun 2019
Resumen:
Introduction: Sodium caseinate (CS) and its components (alpha-casein, beta-casein and kappa-casein) have been shown to inhibit the proliferation of the mouse hematopoietic 32D cl3 cell line and induce its differentiation into macrophages. It is known that alpha-casein induce lL-1 beta production and this cytokine inhibits the proliferation by production of tumor necrosis factor alpha (TNF-alpha), but it is not known if CS and the caseins inhibit the proliferation by TNF-alpha production. Objective: Evaluate if CS and alpha-casein, beta-casein and kappa-casein inhibit the proliferation on 32D cl3 cell line via TNF-alpha. Objective: Evaluate if CS and alpha-casein, beta-casein and kappa-casein inhibit the proliferation on 32D cl3 cell line via TNF-alpha. Materials and methods: To evaluate cell proliferation, different concentrations of CS, alpha-casein, beta-casein and kappa-casein were used on 32D cl3 cells. Cell viability was assessed by MTT, induction to apoptosis by flow cytometry and TNF-alpha synthesis by ELISA. Additionally, anti-TNF-alpha neutralization assays were performed on 32D cells treated with CS and alpha-casein and proliferation was evaluated. Results: The results show that CS, alpha-casein, beta-casein and kappa-casein reduce proliferation of the 32D cl3 cell line, without effect on viability, and only CS and alpha-casein induce apoptosis and release of TNF-alpha. The 32D cl3 cells treated with CS and alpha-casein reestablished their proliferation by using antibodies anti-TNF-alpha. Conclusion: TNF-alpha is principally responsible for the inhibition of proliferation in 32D cl3 cells treated with CS or alpha-casein.

Filiaciones:
Weiss-Steider, Benny:
 Univ Nacl Autonoma Mexico, Fac Estudios Super Zaragoza, Lab Hematopoyesis & Leucemia, Mexico City, DF, Mexico

Cordova, Yolanda:
 Univ Nacl Autonoma Mexico, Fac Estudios Super Zaragoza, Lab Hematopoyesis & Leucemia, Mexico City, DF, Mexico

Aguiniga-Sanchez, Itzen:
 Univ Nacl Autonoma Mexico, Fac Estudios Super Zaragoza, Lab Hematopoyesis & Leucemia, Mexico City, DF, Mexico

Ledesma-Martinez, Edgar:
 Univ Nacl Autonoma Mexico, Fac Estudios Super Zaragoza, Lab Hematopoyesis & Leucemia, Mexico City, DF, Mexico

Dominguez-Melendez, Vanihamin:
 Univ Veracruzana, Ctr Estudios & Serv Salud, Lab Biol Celular & Mol, Xalapa, Veracruz, Mexico

Santiago-Osorio, Edelmiro:
 Univ Nacl Autonoma Mexico, Fac Estudios Super Zaragoza, Lab Hematopoyesis & Leucemia, Mexico City, DF, Mexico
ISSN: 01204157





Biomedica
Editorial
Instituto Nacional de Salud, AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C, 00000, COLOMBIA, Colombia
Tipo de documento: Article
Volumen: 39 Número: 2
Páginas:
WOS Id: 000449549800006
ID de PubMed: 31529816

MÉTRICAS